The LIVMARLI® (maralixibat) oral solution page is for patients and caregivers in the United States. Please read the full Patient Information at bit.ly/43a2Vu9 for LIVMARLI before continuing. Once-daily LIVMARLI is the first FDA-approved medicine for cholestatic pruritus (itch) in patients with Alagille syndrome who are 3 months of age or older. Whether you or your child are already taking LIVMARLI, or you want to learn more, we hope this page can offer valuable information and can help connect you with other patients on LIVMARLI and their families.
Be the first to know and let us send you an email when LIVMARLI® (maralixibat) oral solution posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
